← Open Payments lookup

NICOLAS DEJONG: Open Payments

NPI 1902204803 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$612 in 29 payments from 8 companies in 2025. Trend: 2023 $257 · 2024 $379 · 2025 $612

Food & beverage: $612
CompanyPaymentsAmount
Novo Nordisk Inc12$227
AstraZeneca Pharmaceuticals LP8$163
Lilly USA, LLC2$55
Amgen Inc.2$48
GlaxoSmithKline, LLC.2$37
Optinose US, Inc.1$29
ABIOMED1$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$24

Products named: Ozempic, AIRSUPRA, MOUNJARO, Wegovy, OTEZLA, TRELEGY ELLIPTA, FARXIGA, Xhance.

Industry payments across CA — which companies pay providers there.